TOPOSAR 50 mg contains Etoposide 50 mg, a cytotoxic anticancer (chemotherapy) medicine used in the treatment of certain types of cancer.
Etoposide works by inhibiting the enzyme topoisomerase II, which is needed for DNA replication in rapidly dividing cancer cells. This leads to DNA damage and death of cancer cells, helping slow or stop tumor growth.
Small cell lung cancer
Testicular cancer
Lymphomas (Hodgkin and non-Hodgkin)
Acute myeloid leukemia (AML)
Other cancers as prescribed by an oncologist
Dose is strictly individualized by a cancer specialist.
Common oral regimen:
Treatment cycles are usually repeated every 3–4 weeks depending on blood counts and response.
Take exactly as prescribed by an oncologist.
Swallow capsule whole with water.
May be taken with or without food (as directed).
Do not skip or double doses.
Regular blood tests are required during treatment.
Nausea and vomiting
Hair loss
Loss of appetite
Low blood counts (anemia, infection risk, bleeding risk)
Mouth sores
Fatigue
This is a chemotherapy medicine and must only be used under specialist supervision
Can cause serious bone marrow suppression
Increases risk of infections and bleeding
Not safe during pregnancy or breastfeeding
Requires frequent monitoring of blood counts, liver, and kidney function
Avoid self-medication or unsupervised use